<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD02250000_2</Organism_ID>
  <Organism>Pig</Organism>
  <Organism_Latin>Sus scrofa</Organism_Latin>
  <UniProt_ID>P04416</UniProt_ID>
  <Seq_Length>124</Seq_Length>
  <Molecule_Weight>13969</Molecule_Weight>
  <Function_Summary>PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.</Function_Summary>
  <Catalytic_Mechanism>Phosphatidylcholine + H(2)O = 1-acylglycerophosphocholine + a carboxylate.</Catalytic_Mechanism>
  <Pfam_ID>PF00068:Phospholip_A2_1</Pfam_ID>
  <Allosteric_Activator_Count>5</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>2</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Group IB phospholipase A2</Alias>
      <Alias>Phospholipase A2, minor isoenzyme</Alias>
      <Alias>Phosphatidylcholine 2-acylhydrolase 1B</Alias>
      <Alias>PLA2</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with calcium ions (Ca2+).</Detail>
      <Keyword>Calcium ion binding</Keyword>
      <Ontology_ID>GO:0005509</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate.</Detail>
      <Keyword>Phospholipase A2 activity</Keyword>
      <Ontology_ID>GO:0004623</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester.</Detail>
      <Keyword>Phospholipid metabolic process</Keyword>
      <Ontology_ID>GO:0006644</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.</Detail>
      <Keyword>Lipid catabolic process</Keyword>
      <Ontology_ID>GO:0016042</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>ALWQFRSMIKCTIPGSDPLLDFNNYGCYCGLGGSGTPVDELDRCCETHDNCYRDAKNLDSCKFLVDNPYTNSYSYSCSNTEITCNSKNNACEAFICNCDRNAAICFSKAPYNKEHKNLDTKKYC</Protein_Seq>
    <DNA_Seq>GCTTTTGCTCACCAACCTGACAGCAGGATGAAATTCCTCGTGTTGGCTGTTCTGCTCACAGTGGGCGCTGCCCAGGAAGGCATCAGCTCAAGGGCATTATGGCAGTTTCGTAGCATGATTAAGTGCGCAATCCCCGGCAGTCACCCCTTGATGGATTTCAACAACTATGGCTGCTACTGTGGCCTAGGTGGATCAGGGACCCCTGTGGATGAACTGGACAGGTGCTGCGAGACACACGACAACTGCTACAGAGATGCCAAGAACCTGGACAGCTGTAAATTCCTCGTGGACAATCCCTACACCGAAAGCTACTCCTACTCATGTTCTAACACTGAGATCACCTGCAACAGCAAAAACAATGCTTGTGAGGCCTTCATCTGTAACTGTGACCGAAATGCTGCCATTTGCTTCTCAAAGGCCCCATACAACAAGGAGCACAAGAACCTGGACACCAAGAAGTACTGTTAGAGCTAAGTATCACCC</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Pancreas</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Genbank_ACCN>Y00146</Genbank_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/445525</Gene_URL>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of porcine pancreatic phospholipase A2 complexed with berberine</PDB_Title>
      <PDB_ID>3L69</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=3L69</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>BERBERINE</Ligand_Name>
      <PubMed_Title>Crystal structure of porcine pancreatic phospholipase A2 complexed with berberine</PubMed_Title>
      <Author>Naveen C, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of porcine pancreatic phospholipase A2 complexed with dihydroxyberberine</PDB_Title>
      <PDB_ID>3L30</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=3L30</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>4,14-dihydro-8H-[1,3]dioxolo[4,5-g]isoquino[3,2- a]isoquinoline-9,10-diol</Ligand_Name>
      <PubMed_Title>Crystal structure of porcine pancreatic phospholipase A2 complexed with dihydroxyberberine</PubMed_Title>
      <Author>Naveen C, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Taurochenodeoxycholate</PDB_Title>
      <PDB_ID>2B01</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2B01</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>TAUROCHENODEOXYCHOLIC ACID</Ligand_Name>
      <PubMed_Title>Structural basis for bile salt inhibition of pancreatic phospholipase A2.</PubMed_Title>
      <Author>Pan YH, et al.</Author>
      <Journal>(2007) J.Mol.Biol. 369: 439-450</Journal>
      <PubMed_ID>17434532</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with 2-methoxycyclohexa-2-5-diene-1,4-dione</PDB_Title>
      <PDB_ID>3HSW</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=3HSW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2-methoxycyclohexa-2,5-diene-1,4-dione</Ligand_Name>
      <PubMed_Title>Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with 2-methoxycyclohexa-2-5-diene-1,4-dione</PubMed_Title>
      <Author>Dileep KV, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Glycocholate</PDB_Title>
      <PDB_ID>2B00</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2B00</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLYCOCHOLIC ACID</Ligand_Name>
      <PubMed_Title>Structural basis for bile salt inhibition of pancreatic phospholipase A2.</PubMed_Title>
      <Author>Pan YH, et al.</Author>
      <Journal>(2007) J.Mol.Biol. 369: 439-450</Journal>
      <PubMed_ID>17434532</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of disulfide engineered porcine pancratic phospholipase a2 to group-x isozyme</PDB_Title>
      <PDB_ID>1Y6P</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=1Y6P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Kinetic and structural properties of disulfide engineered phospholipase A2: insight into the role of disulfide bonding patterns.</PubMed_Title>
      <Author>Yu BZ, et al.</Author>
      <Journal>(2005) Biochemistry 44: 3369-3379</Journal>
      <PubMed_ID>15736947</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Taurocholate</PDB_Title>
      <PDB_ID>2AZZ</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2AZZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>TAUROCHOLIC ACID</Ligand_Name>
      <PubMed_Title>Structural basis for bile salt inhibition of pancreatic phospholipase A2.</PubMed_Title>
      <Author>Pan YH, et al.</Author>
      <Journal>(2007) J.Mol.Biol. 369: 439-450</Journal>
      <PubMed_ID>17434532</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Taurochenodeoxycholate</PDB_Title>
      <PDB_ID>2B03</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2B03</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>TAUROCHENODEOXYCHOLIC ACID</Ligand_Name>
      <PubMed_Title>Structural basis for bile salt inhibition of pancreatic phospholipase A2.</PubMed_Title>
      <Author>Pan YH, et al.</Author>
      <Journal>(2007) J.Mol.Biol. 369: 439-450</Journal>
      <PubMed_ID>17434532</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of disulfide engineered porcine pancreatic phospholipase A2 to group-X isozyme in complex with inhibitor MJ33 and phosphate ions</PDB_Title>
      <PDB_ID>1Y6O</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=1Y6O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>1-HEXADECYL-3-TRIFLUOROETHYL-SN-GLYCERO-2- PHOSPHATE METHANE</Ligand_Name>
      <PubMed_Title>Kinetic and structural properties of disulfide engineered phospholipase A2: insight into the role of disulfide bonding patterns.</PubMed_Title>
      <Author>Yu BZ, et al.</Author>
      <Journal>(2005) Biochemistry 44: 3369-3379</Journal>
      <PubMed_ID>15736947</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Cholate</PDB_Title>
      <PDB_ID>2AZY</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2AZY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CHOLIC ACID</Ligand_Name>
      <PubMed_Title>Structural basis for bile salt inhibition of pancreatic phospholipase A2.</PubMed_Title>
      <Author>Pan YH, et al.</Author>
      <Journal>(2007) J.Mol.Biol. 369: 439-450</Journal>
      <PubMed_ID>17434532</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Glycochenodeoxycholate</PDB_Title>
      <PDB_ID>2B04</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2B04</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLYCOCHENODEOXYCHOLIC ACID</Ligand_Name>
      <PubMed_Title>Structural basis for bile salt inhibition of pancreatic phospholipase A2.</PubMed_Title>
      <Author>Pan YH, et al.</Author>
      <Journal>(2007) J.Mol.Biol. 369: 439-450</Journal>
      <PubMed_ID>17434532</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00590</Pathway_ID>
      <Pathway_Title>Arachidonic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00592</Pathway_ID>
      <Pathway_Title>alpha-Linolenic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04975</Pathway_ID>
      <Pathway_Title>Fat digestion and absorption</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Digestive system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04014</Pathway_ID>
      <Pathway_Title>Ras signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00564</Pathway_ID>
      <Pathway_Title>Glycerophospholipid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04972</Pathway_ID>
      <Pathway_Title>Pancreatic secretion</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Digestive system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00591</Pathway_ID>
      <Pathway_Title>Linoleic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00565</Pathway_ID>
      <Pathway_Title>Ether lipid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04270</Pathway_ID>
      <Pathway_Title>Vascular smooth muscle contraction</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Circulatory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00565</Pathway_ID>
      <Pathway_Title>Ether lipid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00564</Pathway_ID>
      <Pathway_Title>Glycerophospholipid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All alpha proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.b.chf.b.b.html</SCOP_URL>
    <CATH_Class>Mainly alpha</CATH_Class>
    <CATH_URL>http://www.cathdb.info/cathnode/1.20.90</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,48,His;site,52,Tyr;range,57,72</Site_Detail>
      <Site_Reference>Yu BZ, et al. Biochemistry. 2009,48(14):3219-3229.</Site_Reference>
      <Site_Type>R-T transition</Site_Type>
      <PubMed_ID>19301848</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.1.1.4</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/1/1/4.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00240009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02250001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02250002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02250003</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02250004</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02250005</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02250006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>